Loading data
AVPTNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 419.5 m USD | 330.48 m USD | 271.83 m USD | 232.34 m USD | 191.91 m USD |
| Cost of revenue | 108.8 m USD | 82.53 m USD | 77.46 m USD | 66.28 m USD | 53 m USD |
| Gross profit | 310.7 m USD | 247.96 m USD | 194.37 m USD | 166.06 m USD | 138.91 m USD |
| Research and development expense | 52.59 m USD | 48.7 m USD | 36.34 m USD | 31.36 m USD | 32.14 m USD |
| Operating profit | 33.04 m USD | 7.17 m USD | -15.35 m USD | -41.07 m USD | -53.49 m USD |
| Profit before tax | 40.5 m USD | -24.4 m USD | -18.61 m USD | -33.65 m USD | -32.79 m USD |
| Income tax expense | 5.38 m USD | 4.74 m USD | 2.89 m USD | 5.04 m USD | 457 k USD |
| Net income (reported basis) | 35.1 m USD | -29 m USD | -21.5 m USD | -38.7 m USD | -33.2 m USD |
| Net income attributable to common shareholders | 34.8 m USD | -29.09 m USD | -21.73 m USD | -41.63 m USD | -68.15 m USD |
| Basic earnings per share | 0.17 USD/share | -0.16 USD/share | -0.12 USD/share | -0.23 USD/share | -0.48 USD/share |
| Diluted earnings per share | 0.15 USD/share | -0.16 USD/share | -0.12 USD/share | — | — |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.